Fil de navegació
Melanoma: imatge, genètica i immunologia
Publicacions destacades
-
Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)
Oro-Ayude, M; Gonzalez-Sixto, B; Sanmartin-Jimenez, O; Garces, JR; Rodriguez-Prieto, MA;(...)Suarez-Fernandez, R; Sainz-Gaspar, L; Descalzo, MA; Garcia-Doval, I; Florez, A.Referència:Journal Of The European Academy Of Dermatology And Venereology 2022.
-
Detection of cell-free circulating BRAFV 600E by droplet digital PCR in melanoma and non-melanoma patients under dermatological surveillance
Calbet-Llopart, N; Potrony, M; Tell-Marti, G; Carrera, C; Barreiro, A;Aguilera, P; Podlipnik, S; Puig, S; Malvehy, J; Puig-Butille, J A.Referència:British Journal Of Dermatology 2020.
-
Inherited MC1R variants in melanoma patients are associated with better survival in females
Lira, F E; Podlipnik, S; Potrony, M; Tell-Marti, G; Calbet-Llopart, N;Barreiro, A; Carrera, C; Malvehy, J; Puig, S.Referència:British Journal Of Dermatology 2020.
-
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
Potrony, M; Puig-Butille, J A; Ribera-Sola, M; Iyer, V; Robles-Espinoza, C D;(...)Malvehy, J; Badenas, C; Landi, M T; Adams, D J; Puig, S.Referència:British Journal Of Dermatology 2019.
-
Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.
Podlipnik, S; Moreno-Ramirez, D; Carrera, C; Barreiro, A; Manubens, E;Ferrandiz-Pulido, L; Sanchez, M; Vidal-Sicart, S; Malvehy, J; Puig, S.Referència:British Journal Of Dermatology 2019.
-
Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients
Podlipnik, S; Carrera, C; Boada, A; Richarz, N A; Lopez-Estebaranz, J L;(...)Carrillo-Gijon, R; Redondo, P; Moreno, E; Malvehy, J; Puig, S.Referència:Journal Of The European Academy Of Dermatology And Venereology 2019.
-
Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations
Martins da Silva, Vanessa; Martinez-Barrios, Estefania; Tell-Marti, Gemma; Dabad, Marc; Carrera, Cristina;(...)Esteve-Codina, Anna; Vicente, Asuncion; Puig, Susana; Anton Puig-Butille, Joan; Malvehy, Josep.Referència:Journal Of Investigative Dermatology 2019.
-
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Eggermont, Alexander M M; Blank, Christian U; Mandala, Mario; Long, Georgina, V; Atkinson, Victoria;(...)Ibrahim, Nageatte; Marreaud, Sandrine; van Akkooi, Alexander C J; Suciu, Stefan; Robert, Caroline.Referència:New England Journal Of Medicine 2018.
-
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.
Gabriela Vallone, Maria; Tell-Marti, Gemma; Potrony, Miriam; Rebollo-Morell, Aida; Badenas, Celia;Anton Puig-Butille, Joan; Gimenez-Xavier, Pol; Carrera, Cristina; Malvehy, Josep; Puig, Susana.Referència:Pigment Cell & Melanoma Research 2018.
-
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study
Podlipnik, Sebastian; Carrera, Cristina; Sanchez, Marcelo; Arguis, Pedro; Olondo, Maria L;(...)Vidal-Sicart, Sergi; Vilalta, Antonio; Conill, Carles; Malvehy, Josep; Puig, Susana.Referència:Journal Of The American Academy Of Dermatology 2016.